Renalytix (FRA:2O9A) Cash And Cash Equivalents : €0.82 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Renalytix Cash And Cash Equivalents?

Renalytix's quarterly cash and cash equivalents increased from Mar. 2024 (€4.33 Mil) to Jun. 2024 (€4.35 Mil) but then stayed the same from Jun. 2024 (€4.35 Mil) to Sep. 2024 (€0.82 Mil).

Renalytix's annual cash and cash equivalents declined from Jun. 2022 (€39.10 Mil) to Jun. 2023 (€22.78 Mil) and declined from Jun. 2023 (€22.78 Mil) to Jun. 2024 (€4.35 Mil).

Renalytix Cash And Cash Equivalents Historical Data

The historical data trend for Renalytix's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Cash And Cash Equivalents Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Cash And Cash Equivalents

Get a 7-Day Free Trial

11.80

54.08

39.10

22.78

4.35

Renalytix Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash And Cash Equivalents	Get a 7-Day Free Trial															13.02	5.15	4.33	4.35	0.82

Renalytix Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Renalytix (FRA:2O9A) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Renalytix Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Renalytix's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (FRA:2O9A) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

RNLXY:USA RTNXF:USA RENX:UK

Address

2 Leman Street, London, GBR, E1W 9US

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix Headlines

No Headlines